Barry, OppHub America Desk · · Source: yahoo-tickers-tape-movers
Intuitive Surgical: Options Price Large Swings Ahead
- If options markets are pricing significant volatility, investors should assess their position sizing in , particularly if they cannot tolerate a move below $236 over the next year. - Watch for potential swings as the market digests procedure growth trends and the impact of instrument cost resets.
Based on reporting from yahoo-tickers-tape-movers.
Intuitive Surgical ($ISRG+WL) stock has declined 38.2% year-to-date, underperforming the S&P 500. Options markets are pricing significant potential volatility for the shares over the next year, suggesting substantial price swings are anticipated despite recent procedure growth moderation.
Market context for this story
As of: After HoursLoading quotes…
Informational only — not investment advice. Full markets →
$SPYSPDR S&P 500 ETF
TradingView
Live chart & market data via TradingView · OppHub classroom · Delayed or exchange real-time per TradingView data agreements · Not investment advice
Educational TradingView chart — search any symbol in the widget. Confirm on /markets/SPY and related $ISRG. Not investment advice.
Related markets
Shares a vertical MP4 loop to your phone's camera roll or app share sheet (Instagram, TikTok, Facebook Reels).
Options on Intuitive Surgical ($ISRG+WL) are pricing in considerable future price action, with implied volatility of 38.9% suggesting a two-thirds chance the stock will trade between $236 and $519 within the next year. This range implies potential downside of approximately $110 and upside of $169 from the current trading level of around $350.16. The stock has experienced a challenging year, down 25% over the trailing twelve months compared to the S&P 500's 19.3% gain, and currently sits about 41% below its 52-week high.
Procedure growth for the da Vinci system in the U.S. has moderated, slowing to 12% in the second quarter of 2026 from 14% in the first quarter. Management attributed this to the law of large numbers and deferrable procedures, with some commentary suggesting insurance coverage changes might be a factor, though other medical technology companies are not reporting similar effects. Additionally, the use of GLP-1 drugs is impacting bariatric cases. However, da Vinci system placements rose 18% year-over-year in Q2 2026, driven by demand for the da Vinci 5 model.
Revenue for ISRG grew 20.7% over the trailing twelve months, and the company maintains a three-year peak operating margin. The current options pricing appears to reflect the uncertainty surrounding the resolution of U.S. procedure growth questions and the impact of instrument cost resets, which management expects to unfold progressively through 2027. The options market suggests a roughly 16% probability that the stock could fall below $236 within the year.
Read the full story
Original reporting and related coverage — attribution links only, not paid recommendations.
Broker and exchange buttons use invite / refer-a-friend links (rewards may be capped). Charting links (TradingView) are partner offers that may pay OppHub America a commission at no extra cost to you.
OppSHOP
Full OppSHOP →As an Amazon Associate, OppHub America earns from qualifying purchases. Shopping here helps keep the site free — at no extra cost to you. Disclosure

OppSHOP
Related to this story
- If options markets are pricing significant volatility, investors shoul
Shop related →

Investing books
Read the classics
Shop this pick →

Personal finance books
Run the household books
Shop this pick →

Trading notebooks
Write the thesis first
Shop this pick →

Monitor for charts
See every pane
Shop this pick →
Story playbook
A pre-built map of what to watch — stocks, ETFs, and educational next steps. Not personalized advice.
Snapshot date: September 9, 2026 at 5:25 PM ET
This playbook was built when the story published and is not live-updated. Prices, news, and risk can change after this date — treat it as a starting map, not a current trade ticket.
Story → money map
medical technology volatility
Intuitive Surgical stock is experiencing a rough year and options markets expect wild price swings ahead. Investors care because slowing medical procedures and new competition create uncertainty about the company's future growth.
What changed
Options markets are pricing large price swings for Intuitive Surgical amid moderating procedure growth and sector uncertainty.
Who wins / who loses
Diversified medical technology suppliers and broader healthcare ETFs benefit from relative stability, while single-stock robotic surgery pure-plays face heightened volatility.
Time horizon
Think in terms of the next few months.
Confidence & best fit
medium confidence · Long-term investor, Active trader
Safer theme exposure (ETFs)
Baskets that own the theme without betting on one company.
Single stocks (higher risk)
Primary = closest to the story · Peers = same industry · Second-order = knock-on effects · Avoid = looks related but may be a trap
Primary
- $ISRGWatch — track, don’t rush
This is the main company in the news; because its stock is bouncing around wildly, it is safer to watch from the sidelines until things settle down.
View $ISRG chart → · End-of-day delayed data
Peer
- $MDTWatch — track, don’t rush
Established medical giants can serve as a comparison to see if the whole healthcare device sector is slowing down.
View $MDT chart → · End-of-day delayed data
- $SYKWatch — track, don’t rush
Another company that makes surgical tools; if Intuitive struggles, competitors might capture investor attention.
View $SYK chart → · End-of-day delayed data
Options (education only)
No strikes or expiries — a framework for how traders might express the view. Options can expire worthless.
Direction: volatile · Style: Protective put / downside hedge idea · Level: intermediate
Beginners should skip options here because prices are expensive due to high expected volatility; use simple stock monitoring instead.
Income / OppHub America angle
Not a trade tip — ways to use the insight outside the market.
- Research broader healthcare service trends and hospital capital expenditure budgets.
What would break this thesis
- Rebound in quarterly procedure growth rates above historical averages and stabilization of instrument cost resets.
What to do next on OppHub America
Saved playbooks stay on this device for now.
Important
Not financial advice. OppHub America playbooks are educational market maps only — not recommendations to buy, sell, or hold any security. Markets move fast; information can be wrong or outdated. Trade and invest at your own risk. Do your own research or consult a licensed advisor.
Based on reporting from yahoo-tickers-tape-movers.
Informational and educational only — not investment, financial, or legal advice. Disclosure
Shares a vertical MP4 loop to your phone's camera roll or app share sheet (Instagram, TikTok, Facebook Reels).